Related references
Note: Only part of the references are listed.The analysis of competing events like cause-specific mortality-beware of the Kaplan-Meier method
Marion Verduijn et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study
Dimitrios J. Tsakiris et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Measures of Disease Frequency: Prevalence and Incidence
Marlies Noordzij et al.
NEPHRON CLINICAL PRACTICE (2010)
Risk of Fractures After Renal Transplantation in the United States
Lucas E. Nikkel et al.
TRANSPLANTATION (2009)
Association of activated vitamin D treatment and mortality in chronic kidney disease
Csaba P. Kovesdy et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Measuring disease occurrence
K. J. Jager et al.
KIDNEY INTERNATIONAL (2007)
The logrank test
JM Bland et al.
BRITISH MEDICAL JOURNAL (2004)
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls
SJ Pocock et al.
LANCET (2002)
Share Paper
